We used MOLM-13 and MV4-11 cells, which represent two AML cell lines harboring MLL rearrangements together with the FLT3-ITD mutations, as we previously demonstrated that those cell lines are sensitive to SETD2 perturbation [12]. The gene discussed is FLT3; the disease is acute myeloid leukemia.